top of page

NEW EVENT THIS THURSDAY! New drug for HER2+ Breast Cancer


FDA Approved for Adult Patients with HER2+ unresectable or metastatic breast cancer after two or more prior anti-HER2-based regimens in the metastatic setting! Learn more!


See program details below! Grab a seat!



1 Comment


This event has been rescheduled to April 26th, 2022. New event info coming soon...

Like
BONS logo.png

Contact:

Daunielle Ricardi, President

Alissa Gentile, Treasurer

Cameron Keith, Social Media Coordinator

Email: BonsSocialMedia@gmail.com

  • Facebook
  • Instagram
  • LinkedIn
Earthen Media-4.png
bottom of page